Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP on Nasdaq, is a special purpose acquisition company targeting opportunities in the biopharmaceutical and life sciences sector. The vehicle, which completed its initial public offering in 2021, filed a Form 10-Q with the Securities and Exchange Commission on November 8, 2023, documenting its continued status as a publicly listed blank check company active in the healthcare deal market. As of that quarterly filing, PWUP remains a tracked participant in the SPAC universe with a biopharma sector mandate. Investors and analysts seeking full filing history, sponsor intelligence, and deal-timeline data for PWUP can sign up for complete coverage on SpacDesk.